There is no way to fully eliminate HSV-1 from your body once you’ve been infected. The virus embeds itself in nerve cells, where it remains for life in a dormant state that current medications cannot reach. That said, outbreaks can be managed effectively, shedding decreases significantly over time, and gene-editing research is closer than ever to a true cure. Understanding what you’re dealing with puts you in a much better position to control it.
Why HSV-1 Can’t Be Cured Yet
HSV-1 infects roughly 3.8 billion people under age 50 worldwide, about 64% of the global population. Most people pick it up in childhood through casual contact like a kiss from a relative. After the initial infection, the virus travels along nerve fibers and settles into clusters of nerve cells called sensory ganglia, most commonly near the base of the skull. There, it enters a dormant phase where it produces no new virus particles and causes no symptoms.
This is the core problem. Antiviral medications work by interrupting viral replication, but a dormant virus isn’t replicating. It’s just sitting quietly inside your neurons, its DNA tucked away where your immune system and medications can’t effectively clear it. Your body actually stations immune cells near these nerve clusters to keep the virus in check, but HSV-1 has evolved mechanisms to avoid being destroyed by them. The virus essentially hides in a biological blind spot.
What Antiviral Medications Actually Do
Antiviral drugs are the most effective tool available right now. They don’t eliminate the virus, but they shorten outbreaks, reduce their severity, and lower the chance of passing HSV-1 to someone else. The three main options all work through the same basic mechanism: they block the virus from copying itself once it reactivates.
There are two ways antivirals are typically used. Episodic therapy means you take medication at the first sign of an outbreak (tingling, itching, or redness) and continue for a few days. Starting within the first 24 hours makes the biggest difference. This approach works well for people who get occasional cold sores and can recognize their early warning signs.
Suppressive therapy means taking a low dose of antiviral medication every day, whether or not you have symptoms. This approach is generally reserved for people with frequent recurrences. The CDC notes that because HSV-1 tends to recur less often than HSV-2, daily suppressive therapy should be a shared decision between you and your provider based on how often outbreaks are disrupting your life. If you’re getting outbreaks every month or two, it’s worth discussing. If you get one cold sore a year, episodic treatment is usually sufficient.
Outbreaks Naturally Decrease Over Time
One of the most reassuring things about HSV-1 is that your body gets better at suppressing it as time goes on. Research from the University of Washington tracked viral shedding (periods when the virus is active on the skin, often without visible sores) and found a clear downward trend. At two months after initial infection, participants shed the virus on about 12% of days. By 11 months, that dropped to 7%. Among those who shed the most at 11 months, a follow-up two years after infection showed shedding had plummeted to just 1.3% of days.
Most of this shedding happened without any visible symptoms. So while the virus does become active periodically, those episodes become shorter, less frequent, and less intense the longer you carry it. Many people find that after the first year or two, outbreaks become rare or stop entirely without any medication.
Common Triggers for Reactivation
When the dormant virus does wake up, it’s usually in response to a specific trigger. Knowing your personal triggers lets you take steps to reduce how often outbreaks happen.
- UV exposure: Sunlight is one of the most well-documented triggers. In controlled studies, UV light reactivated herpes infections within about four to five days in the majority of attempts. If sun exposure tends to precede your cold sores, using SPF lip balm and limiting prolonged direct sun on your face can help.
- Physical stress on the body: Fever, illness, surgery (especially dental or facial procedures), and hormonal shifts like menstruation are all associated with reactivation. The virus responds to signals of physiological stress in the nerve cells where it lives.
- Psychological stress and fatigue: Sleep deprivation and prolonged emotional stress weaken immune surveillance, giving the virus a window to reactivate. This is one of those triggers that’s easy to identify in hindsight but harder to control in real life.
- Skin trauma: Chapped lips, windburn, or cosmetic procedures on the face can provoke an outbreak in the area where the virus typically surfaces.
You can’t eliminate every trigger, but layering small preventive habits (consistent sun protection, managing sleep, starting antivirals before a known stressor like dental work) meaningfully reduces outbreak frequency for most people.
Reducing Transmission to Others
Because HSV-1 sheds asymptomatically, it’s possible to transmit the virus even when you have no visible sore. That said, the risk is highest during active outbreaks and drops substantially over time. Avoiding kissing or oral contact during outbreaks is the most important step. If you have genital HSV-1, using barriers during sex and considering suppressive antiviral therapy during a new relationship reduces transmission risk further.
Context matters here. Given that nearly two-thirds of the global population already carries HSV-1, many partners will have already been exposed. Still, having an honest conversation with a partner lets them make informed choices, and suppressive therapy combined with barrier methods brings transmission risk down considerably.
Gene Therapy Research Is Progressing
The closest thing to a potential cure on the horizon comes from gene-editing research at Fred Hutch Cancer Center. Their approach uses a specially designed enzyme delivered directly to infected nerve cells, where it cuts the dormant viral DNA in two places, effectively destroying it. In mouse models, this therapy eliminated 90% of HSV-1 after oral infection and 97% after genital infection. It also suppressed how much virus could be shed from treated animals.
The team has simplified their approach over successive studies, moving from three delivery vehicles and two cutting enzymes down to just one of each. They are currently collaborating with partners and working with federal regulators to prepare for human clinical trials, though no timeline for those trials has been publicly announced. This is still pre-clinical work, meaning it has not yet been tested in people. But it represents the first realistic path toward actually removing the virus from the body rather than just managing symptoms.
Living With HSV-1 in Practical Terms
For most people, HSV-1 is a minor inconvenience rather than a serious health concern. The first outbreak is typically the worst. After that, your immune system builds a strong response that keeps the virus suppressed the vast majority of the time. Many carriers go years between outbreaks, or never have a recognizable one at all.
If outbreaks are affecting your quality of life, talk to a healthcare provider about whether episodic or suppressive antiviral therapy makes sense for your situation. Keep antivirals on hand so you can start treatment at the first sign of a recurrence. Pay attention to your personal triggers and take basic preventive steps like sun protection and stress management. And know that the trajectory is almost always toward fewer and milder episodes as time goes on.